社区中使用阿片类药物的创伤暴露个体中,创伤后应激障碍对阿片类药物日常使用轨迹的影响

IF 2.6 4区 医学 Q3 PSYCHIATRY
Nicole H Weiss, Noam G Newberger, Alexa M Raudales, Emmanuel D Thomas, Prachi Bhuptani, Colin T Mahoney, Ateka A Contractor
{"title":"社区中使用阿片类药物的创伤暴露个体中,创伤后应激障碍对阿片类药物日常使用轨迹的影响","authors":"Nicole H Weiss, Noam G Newberger, Alexa M Raudales, Emmanuel D Thomas, Prachi Bhuptani, Colin T Mahoney, Ateka A Contractor","doi":"10.1080/15504263.2025.2559173","DOIUrl":null,"url":null,"abstract":"<p><p><b>Objective:</b> Individuals who use opioids are at elevated risk of posttraumatic stress disorder (PTSD). The objective of this study was to examine the influence of PTSD diagnosis on opioid use outcomes over a 60-day period. <b>Methods:</b> Participants were individuals with a history of trauma and recent opioid use who were recruited from the community (<i>M<sub>age</sub></i> = 43.45 years; 54.8% white). Participants were administered a structured diagnostic assessment for PTSD during a baseline session, and reported 30-day opioid use, opioid treatment engagement, impaired control around using opioids, and opioid overdose using a Timeline Follow-back during baseline (<i>N =</i> 84) and follow-up (<i>N =</i> 56) sessions. Multilevel models were used to examine the influence of PTSD on change in opioid use, treatment, and impaired control over the course of the 60-day observation period among the 56 individuals that completed follow-up interviews. <b>Results:</b> Two-thirds of the sample had a diagnosis of PTSD (66.7%). Compared to those without PTSD, individuals with PTSD were less likely to decrease opioid use (<i>OR</i> = 1.04, 95% CI [1.02, 1.06], <i>p</i> < .001), but were not more likely to report episode of impaired control (<i>OR</i> = 1.02, 95% CI [0.98, 1.06], <i>p</i> = .268), over the 60-day period. Although individuals with PTSD were less likely to increase their engagement with opioid treatment (<i>OR</i> = 0.96, 95% CI [0.95, 0.97], <i>p</i> < .001), these individuals engaged in treatment at much higher levels compared to individuals without PTSD. <b>Conclusions:</b> Findings underscore the high prevalence and impact of PTSD on opioid use outcomes among trauma-exposed community individuals who use opioids.</p>","PeriodicalId":46571,"journal":{"name":"Journal of Dual Diagnosis","volume":" ","pages":"1-13"},"PeriodicalIF":2.6000,"publicationDate":"2025-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Influence of Posttraumatic Stress Disorder on Daily-Level Trajectories of Opioid Use Among Trauma-Exposed Individuals in the Community Who Use Opioids.\",\"authors\":\"Nicole H Weiss, Noam G Newberger, Alexa M Raudales, Emmanuel D Thomas, Prachi Bhuptani, Colin T Mahoney, Ateka A Contractor\",\"doi\":\"10.1080/15504263.2025.2559173\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Objective:</b> Individuals who use opioids are at elevated risk of posttraumatic stress disorder (PTSD). The objective of this study was to examine the influence of PTSD diagnosis on opioid use outcomes over a 60-day period. <b>Methods:</b> Participants were individuals with a history of trauma and recent opioid use who were recruited from the community (<i>M<sub>age</sub></i> = 43.45 years; 54.8% white). Participants were administered a structured diagnostic assessment for PTSD during a baseline session, and reported 30-day opioid use, opioid treatment engagement, impaired control around using opioids, and opioid overdose using a Timeline Follow-back during baseline (<i>N =</i> 84) and follow-up (<i>N =</i> 56) sessions. Multilevel models were used to examine the influence of PTSD on change in opioid use, treatment, and impaired control over the course of the 60-day observation period among the 56 individuals that completed follow-up interviews. <b>Results:</b> Two-thirds of the sample had a diagnosis of PTSD (66.7%). Compared to those without PTSD, individuals with PTSD were less likely to decrease opioid use (<i>OR</i> = 1.04, 95% CI [1.02, 1.06], <i>p</i> < .001), but were not more likely to report episode of impaired control (<i>OR</i> = 1.02, 95% CI [0.98, 1.06], <i>p</i> = .268), over the 60-day period. Although individuals with PTSD were less likely to increase their engagement with opioid treatment (<i>OR</i> = 0.96, 95% CI [0.95, 0.97], <i>p</i> < .001), these individuals engaged in treatment at much higher levels compared to individuals without PTSD. <b>Conclusions:</b> Findings underscore the high prevalence and impact of PTSD on opioid use outcomes among trauma-exposed community individuals who use opioids.</p>\",\"PeriodicalId\":46571,\"journal\":{\"name\":\"Journal of Dual Diagnosis\",\"volume\":\" \",\"pages\":\"1-13\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2025-10-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Dual Diagnosis\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/15504263.2025.2559173\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Dual Diagnosis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/15504263.2025.2559173","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

摘要

目的:使用阿片类药物的个体患创伤后应激障碍(PTSD)的风险较高。本研究的目的是在60天内检查PTSD诊断对阿片类药物使用结果的影响。方法:参与者是从社区招募的有创伤史和近期阿片类药物使用的个体(年龄43.45岁;白人54.8%)。在基线阶段,参与者接受了创伤后应激障碍的结构化诊断评估,并报告了30天的阿片类药物使用情况、阿片类药物治疗参与情况、阿片类药物使用控制受损情况和阿片类药物过量情况,在基线阶段(N = 84)和随访阶段(N = 56)使用时间线进行随访。在60天的观察期内,对56名完成随访访谈的个体进行了多水平模型研究,以检查PTSD对阿片类药物使用、治疗和控制受损的影响。结果:三分之二的样本被诊断为PTSD(66.7%)。与没有PTSD的患者相比,在60天内,PTSD患者减少阿片类药物使用的可能性较小(OR = 1.04, 95% CI [1.02, 1.06], p < .001),但报告控制受损发作的可能性较小(OR = 1.02, 95% CI [0.98, 1.06], p = .268)。虽然PTSD患者增加阿片类药物治疗的可能性较小(OR = 0.96, 95% CI [0.95, 0.97], p < .001),但与没有PTSD的个体相比,这些个体参与治疗的水平要高得多。结论:研究结果强调了在使用阿片类药物的创伤暴露社区个体中,PTSD的高患病率和对阿片类药物使用结果的影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Influence of Posttraumatic Stress Disorder on Daily-Level Trajectories of Opioid Use Among Trauma-Exposed Individuals in the Community Who Use Opioids.

Objective: Individuals who use opioids are at elevated risk of posttraumatic stress disorder (PTSD). The objective of this study was to examine the influence of PTSD diagnosis on opioid use outcomes over a 60-day period. Methods: Participants were individuals with a history of trauma and recent opioid use who were recruited from the community (Mage = 43.45 years; 54.8% white). Participants were administered a structured diagnostic assessment for PTSD during a baseline session, and reported 30-day opioid use, opioid treatment engagement, impaired control around using opioids, and opioid overdose using a Timeline Follow-back during baseline (N = 84) and follow-up (N = 56) sessions. Multilevel models were used to examine the influence of PTSD on change in opioid use, treatment, and impaired control over the course of the 60-day observation period among the 56 individuals that completed follow-up interviews. Results: Two-thirds of the sample had a diagnosis of PTSD (66.7%). Compared to those without PTSD, individuals with PTSD were less likely to decrease opioid use (OR = 1.04, 95% CI [1.02, 1.06], p < .001), but were not more likely to report episode of impaired control (OR = 1.02, 95% CI [0.98, 1.06], p = .268), over the 60-day period. Although individuals with PTSD were less likely to increase their engagement with opioid treatment (OR = 0.96, 95% CI [0.95, 0.97], p < .001), these individuals engaged in treatment at much higher levels compared to individuals without PTSD. Conclusions: Findings underscore the high prevalence and impact of PTSD on opioid use outcomes among trauma-exposed community individuals who use opioids.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
4.90
自引率
13.60%
发文量
20
期刊介绍: Journal of Dual Diagnosis is a quarterly, international publication that focuses on the full spectrum of complexities regarding dual diagnosis. The co-occurrence of mental health and substance use disorders, or “dual diagnosis,” is one of the quintessential issues in behavioral health. Why do such high rates of co-occurrence exist? What does it tell us about risk profiles? How do these linked disorders affect people, their families, and the communities in which they live? What are the natural paths to recovery? What specific treatments are most helpful and how can new ones be developed? How can we enhance the implementation of evidence-based practices at clinical, administrative, and policy levels? How can we help clients to learn active recovery skills and adopt needed supports, clinicians to master new interventions, programs to implement effective services, and communities to foster healthy adjustment? The Journal addresses each of these perplexing challenges.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信